Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment

American Journal on Addictions

Volumn 22, Issue 4, 2013, Pages 411-416

  Fareed, Ayman ^a,b   Byrd Sellers, Johnita ^a   Vayalapalli, Sreedevi ^a,b   Drexler, Karen ^a,b   Phillips, Lawrence ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUPRENORPHINE; METHADONE; OPIATE;

ADULT; AFRICAN AMERICAN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION;

BLOOD GLUCOSE; BUPRENORPHINE; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84879501062     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12043.x     Document Type: Article

References (29)

1. Dole VP, Nyswander ME., A medical treatment for diacetyl morphine (heroin) addiction: A clinical trial with methadone hydrochloride. JAMA. 1965; 193: 646-650.
2. Ball JC, Ross A., The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcome. New York: Springer-Verlag; 1991.
3. Eissenberg T, Bigelow GE, Strain EC, et al. Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence: A randomized clinical trial. JAMA. 1997; 277: 1945-1951.
4. Ling W, Charuvastra VC, Kaim SC, et al. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A Veterans Administration cooperative study. Arch Gen Psychiatry. 1976; 33: 709-720.
5. Strain EC, Stitzer ML, Liebson IA, et al. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993; 119: 23-27.
6. Marsch LA., The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: A meta-analysis. Addiction. 1998; 93: 515-532.
7. Fareed A, Musselman D, Byrd-Sellers J, et al. On-site basic health screening and brief health counseling of chronic medical conditions for veterans in methadone maintenance treatment. J Addict Med. 2010; 4: 160-166.
8. Howard AA, Floris-Moore M, Lo Y, et al. Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med. 2006; 7: 389-396.
9. Howard AA, Floris-Moore M, Arnsten JH, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005; 40: 1492-1499.
10. Fareed A, Casarella J, Amar R, et al. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatric Prac. 2009; 15: 227-234.
11. Centers for Disease Control and Prevention. Prevalence of diagnosed diabetes by age, United States, 1980-2005. Available at: www.cdc.gov/diabetes/ statistics/prev/national/figbyage.htm. Accessed January 14, 2009.
12. White DL, Ratziu V, El-Serag HB., Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis. J Hepatol. 2008; 49 (5): 831-844. Epub August 21, 2008.
13. Poussier A, Lebouvier M, Penfornis A, et al. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection. Diabet Med. 2008; 25: 1237-1240.
14. Harrison SA., Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment. Clin Gastroenterol Hepatol. 2008; 6: 864-876. Epub June 27, 2008.
15. Reed JL, Ghodse AH., Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J. 1973; 2: 582-585.
16. Passariello N, Giugliano D, Quatraro A, et al. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin dependent diabetes. Metabolism. 1983; 32: 1163-1165.
17. Ceriello A, Giugliano D, Passariello N, et al. Impaired glucose metabolism in heroin and methadone users. Horm Metabol Res. 1987; 19: 430-433.
18. Vescovi PP, Pezzarossa A, Caccavari R, et al. Glucose tolerance in opiate addicts. Diabetologia. 1982; 23: 459.
19. Sadava D, Alonso D, Hong H, et al. Effect of methadone addiction on glucose metabolism in rats. Gen Pharmacol. 1997; 28: 27-279.
20. Thuluvath PJ, John PR., Association between hepatitis C, diabetes mellitus, and race. A case-control study. Am J Gastroenterol. 2003; 98: 438-441.
21. Arao M, Murase K, Kusakabe A, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol. 2003; 38: 355-360.
22. Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol. 2001; 35: 279-283.
23. Narayan KMV, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290: 1884-1890.
24. Reid RL, Yen SSC., Beta-endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab. 52: 592-594; I98 1.
25. Feldberg VS, Shaligram SV., The hyperglycemic effect of morphine. Br J Pbarmacol. 1972; 46: 602-618.
26. Ipp E, Schusdziarra V, Harris V, et al. Morphine-induced hyperglycemia: Role of insulin and glucagon. Endocrinology. 1980; 107: 461-463.
27. Giugliano D, Ceriello A, Di Pinto P, et al. lmpaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes. 1982; 31: 367-370.
28. Raingeard I, Courtet P, Renard E, et al. Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders. Diabetes Care. 2004; 27: 847-848.
29. Rose AJ, Hermos JA, Frayne SM, et al. Does opioid therapy affect quality of care for diabetes mellitus ? Am J Manag Care. 2009; 15: 217-224.